Goldman Sachs
CLOV icon

Goldman Sachs’s Clover Health Investments CLOV Stock Holding History

Goldman Sachs’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-640,000
Closed -$4.73M – 6483
2021
Q3 		$4.73M Buy
+640,000
New +$5.48M ﹤0.01% 3416

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's CLOV Position: Q1 2026 in Review

Goldman Sachs increased its Clover Health Investments (CLOV) stake by 22% in Q1 2026, buying an estimated $834K and bringing the position to 2,165,562 shares worth $3.81M. The position accounts for ﹤0.01% of the portfolio, ranked #3955.

Goldman Sachs first reported a position in CLOV in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.95M in Q1 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Goldman Sachs held 2,165,562 shares of Clover Health Investments worth $3.81M as of Q1 2026.
  • Goldman Sachs bought 384,323 Clover Health Investments shares in Q1 2026, an estimated $834K.
  • Clover Health Investments made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3955 holding.
  • Goldman Sachs first reported a position in Clover Health Investments in Q4 2020 and has held it in 22 quarters since.
  • Goldman Sachs's Clover Health Investments position peaked at $7.95M in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.